Evidence map›Paper›PMID 22871397›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2013

A secure distributed logistic regression protocol for the detection of rare adverse drug events.

Khaled El Emam, Saeed Samet, Luk Arbuckle, Robyn Tamblyn, Craig Earle, Murat Kantarcioglu

Abstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Privacy-preserving logistic regression with secret sharing.BMC medical informatics and decision making · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Privacy-preserving model learning on a blockchain network-of-networks.Journal of the American Medical Informatics Association : JAMIA · 2020
    Article
  16. Article
  17. Article
  18. Predicting Adverse Drug Reactions on Distributed Health Data using Federated Learning.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Khaled El EmamCHEO Research Institute, Ottawa, Ontario, Canada. kelemam@ehealthinformation.ca
Saeed Samet
Luk Arbuckle
Robyn Tamblyn
Craig Earle
Murat Kantarcioglu

Funding

Technologies to Enable Privacy in Biomedical DatabanksR01LM009989 · NLM · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MALIN, BRADLEY A. · 2009 to 2014
$1.6M
NLM NIH HHS 1R01LM009989NLM NIH HHS R01 LM009989
6 · The paper itself

Abstract

backgroundThere is limited capacity to assess the comparative risks of medications after they enter the market. For rare adverse events, the pooling of data from multiple sources is necessary to have the power and sufficient population heterogeneity to detect differences in safety and effectiveness in genetic, ethnic and clinically defined subpopulations. However, combining datasets from different data custodians or jurisdictions to perform an analysis on the pooled data creates significant privacy concerns that would need to be addressed. Existing protocols for addressing these concerns can result in reduced analysis accuracy and can allow sensitive information to leak.

objectiveTo develop a secure distributed multi-party computation protocol for logistic regression that provides strong privacy guarantees.

methodsWe developed a secure distributed logistic regression protocol using a single analysis center with multiple sites providing data. A theoretical security analysis demonstrates that the protocol is robust to plausible collusion attacks and does not allow the parties to gain new information from the data that are exchanged among them. The computational performance and accuracy of the protocol were evaluated on simulated datasets.

resultsThe computational performance scales linearly as the dataset sizes increase. The addition of sites results in an exponential growth in computation time. However, for up to five sites, the time is still short and would not affect practical applications. The model parameters are the same as the results on pooled raw data analyzed in SAS, demonstrating high model accuracy.

conclusionThe proposed protocol and prototype system would allow the development of logistic regression models in a secure manner without requiring the sharing of personal health information. This can alleviate one of the key barriers to the establishment of large-scale post-marketing surveillance programs. We extended the secure protocol to account for correlations among patients within sites through generalized estimating equations, and to accommodate other link functions by extending it to generalized linear models.

Indexed as

Logistic ModelsBiostatisticsComputer Communication NetworksDrug-Related Side Effects and Adverse ReactionsHumansProduct Surveillance, Postmarketing

Identifiers

PMID22871397
PMCPMC3628043

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.